APA (7th ed.) Citation

S, S., G, C., S, K., S, C., JS, W., & F, L. (2023). The impact of relapse definition and measures of durability on MS clinical trial outcomes. Multiple sclerosis (Houndmills, Basingstoke, England), 29(4-5), 568. https://doi.org/10.1177/13524585231157211

Chicago Style (17th ed.) Citation

S, Satyanarayan, Cutter G, Krieger S, Cofield S, Wolinsky JS, and Lublin F. "The Impact of Relapse Definition and Measures of Durability on MS Clinical Trial Outcomes." Multiple Sclerosis (Houndmills, Basingstoke, England) 29, no. 4-5 (2023): 568. https://doi.org/10.1177/13524585231157211.

MLA (9th ed.) Citation

S, Satyanarayan, et al. "The Impact of Relapse Definition and Measures of Durability on MS Clinical Trial Outcomes." Multiple Sclerosis (Houndmills, Basingstoke, England), vol. 29, no. 4-5, 2023, p. 568, https://doi.org/10.1177/13524585231157211.